1. Kumar CC (2003) Integrin αvβ3 as a therapeutic target for blocking tumor-induced angiogenesis. Curr Drug Targets 4:123–131
2. Brooks PC, Clark RAF, Cheresh DA (1994) Requirement of vascular integrin αvβ3 for angiogenesis. Science 264:569–571
3. Gasparini G, Brooks PC, Biganzoli E, Bonoldi E, Dirix LY, Ranieri G, Miceli R, Cheresh DA (1998) Vascular integrin αvβ3 a new prognostic indicator in breast cancer. Clin Cancer Res 4:2625–2634
4. Albelda SM, Mette SA, Elder DE, Stewart RM, Damjanovich L, Herlyn M, Buck CA (1990) Integrin distribution in malignant melanoma: association of the β 3 subunit with tumor progression. Cancer Res 50:6757–6764
5. Sengupta S, Chattopadhyay N, Mitra A, Ray S, Dasgupta S, Chatterjee A (2001) Role of αvβ3 integrin receptors in breast tumor. J Exp Clin Cancer Res 20:585–590